Development of isoform selective PI3-kinase inhibitors as pharmacological tools for elucidating the PI3K pathway
作者:Ian Bruce、Mohammed Akhlaq、Graham C. Bloomfield、Emma Budd、Brian Cox、Bernard Cuenoud、Peter Finan、Peter Gedeck、Julia Hatto、Judy F. Hayler、Denise Head、Thomas Keller、Louise Kirman、Catherine Leblanc、Darren Le Grand、Clive McCarthy、Desmond O’Connor、Charles Owen、Mrinalini S. Oza、Gaynor Pilgrim、Nicola E. Press、Lilya Sviridenko、Lewis Whitehead
DOI:10.1016/j.bmcl.2012.07.042
日期:2012.9
Using a parallel synthesis approach to target a non-conserved region of the PI3K catalytic domain a pan-PI3K inhibitor 1 was elaborated to provide alpha, delta and gamma isoform selective Class I PI3K inhibitors 21, 24, 26 and 27. The compounds had good cellular activity and were selective against protein kinases and other members of the PI3K superfamily including mTOR and DNA-PK. (C) 2012 Elsevier Ltd. All rights reserved.